CRISPR Therapeutics and ViaCyte’s Strategic Collaboration to Develop Gene‐Edited Stem Cell‐Derived Therapy for Diabetes

Yesterday, CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company that develops transformative gene‐based medicines for serious diseases, and ViaCyte, Inc., a regenerative medicine company, announced their collaboration.

T1D Care in the Wake of Typhoon Mangkhut

Typhoon Mangkhut has slammed the Philippines, Hong Kong and continues a destruction path across Southern China.

Immunotherapy for Type 1 Diabetes

“For a long time, everybody thought that Type 1 would be cured by immunosuppression,” said The Faustman Lab’s Dr. Denise L. Faustman, M.D., Ph.D., but the past 30 years of discovery “have proven that immunostimulation is what’s needed.”

Can an Antihypertensive Drug Preserve Beta Cell Function in Early Type 1 diabetes?

A study published this week in Nature reported that an FDA-approved antihypertensive drug, verapamil, might slow the progression of beta cell destruction at Type 1 diabetes onset.

Eversense from Senseonics – The First Implantable CGM

Could implantable technology be the future of continuous glucose monitoring? Meet the Eversense CGM, made by device company Senseonics.

FDA Approves Basal-IQ Predictive Low Suspend for the t:slim X2 Pump from Tandem

Tandem announces FDA approval of the Basal-IQ™ technology, a predictive low glucose suspend (PLGS) feature designed to help reduce the frequency and duration of low glucose events for the t:slim X2™ Insulin Pump.

Breaking News From #2018ADA

The most important and groundbreaking news coming out of the 78th Scientific Sessions, updated regularly over the course of the conference

Omnipod DASH System from Insulet Receives FDA Clearance

Omnipod DASH(TM) Insulin Management System has received 510(K) clearance from the FDA. This clearance allows Insulet to commercialize this product in the United States, though Insulet has announced that it will begin roll-out through a limited market launch. Full market release is estimated to begin in early 2019 in the United States.

Are You A DIABADASS? – The Diabadass Tour

Cassidy Robinson and Erik Douds are hitting the road again - and want to see you along the way! Find out what the Diabadass Tour is all about.

Cell Replacement and Type 1 Diabetes: Encellin’s Solution

Bay Area start-up Encellin is pursuing pancreatic cell replacement therapy in a more body-palatable form.

Grant Helps ViaCyte Pursue T1D Cure

The California Institute for Regenerative Medicine (CIRM) awarded ViaCyte a $20 million dollar grant to continue its cutting-edge research towards finding a functional cure for T1D.

9 Bad Diabetes Photos

Let's face it - there's a lot of bad diabetes information on the internet. Diabetes stock photography seems to be an especially cringe-worthy corner.

Sam Brand — From Triathlons to Cycling at Team Novo Nordisk

Brand seems like a lucky guy, but I suspect it has more to do with his upbeat attitude, warm demeanor and apparent work ethic. He tells me, “The most important thing I learned at university was routine. Triathlon races there gave me the ability to develop a regime that worked for me. It was a positive combination between sport, studying and diabetes management.”

The Face of Type 1 Diabetes in Developing Countries

Take a look into the life of a child living with Type 1 diabetes in a developing country. The story of Tazul is the story of countless children around the world.

This Halloween, don’t just have diabetes. Be diabetes.

Every year, at the very last second, I scour the Internet for a Halloween costume that will blow my friends and coworkers away. No, I’m not going to be Harambe. No, I’m not going to be Ken Bone. No, I’m not going to be a Pineapple ... again.